Bibliografía del artículo
1. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. JAMA 289:2560-2572, 2003.
2. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attacks Trial, Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic. JAMA 288:2981-2997, 2002.
3. Lopez J, Meier J, Cunningham F, Siegel D. Antihypertensive Medication Use in the Department of Veterans Affairs. Am J Hypertens 17:1095-1099, 2004.
4. Giles TD, Houston MC. J Do diuretics diminish the predicted benefits on ischemic heart disease events of lowering blood pressure in hypertension? Messages from ALLHAT, ACCOMPLISH, and ACCORD. Clin Hypertens (Greenwich) 12:469-471, 2010.
5. Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Eng J Med 321:868-873, 1989.
6. Siegel D, Saliba P, Haffner S. Glucose and insulin levels during diuretic therapy in hypertensive men. Hypertension 23[part 1]:688-694, 1994.
7. Swislocki AL, Hoffman BB, Reaven GM. Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens 2(6):419-423, 1989.
8. Zillich AJ, Garg J, Basu, S, Bakris GL, Carter BL. Thiazide diuretics, potassium, and the development of diabetes. A quantitative review. Hypertension 48:219-224, 2006.
9. Kraus D, Jager J, Meier B, Fasshauer M, Klein J. Aldosterone inhibits uncoupling protein-1, induces insulin resistance, and stimulates proinflammatory adipokines in adipocytes. Horm Metab Res 37:455-459, 2005.
10. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects or treatment on morbidity in hypertension: I. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 202:1028-1034, 1967.
11. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension: II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 213:1143-1152, 1970.
12. Hypertension Detection and Follow Up Program Cooperative Group. Five year findings of the Hypertension detection and Follow-up Program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 242:2562-2571, 1979.
13. Savage PJ, Pressel SL, Curb JD, et al. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative research Group. Arch Int med 158:741-751, 1998.
14. Barzilay JI, Davis BR, Cutler JA, et al. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment. A report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Int Med 166:2191-2201, 2006.
15. Whelton, PK, Barzilay J, Cushman WC, et al. Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration and normoglycemia. Arch Int Med 165:1401-1409, 2005.
16. The ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 362:1575-1585, 2010.
17. Siegel D, Meier J, Maas C, Lopez J, Swislocki ALM. The effect of body mass index on fasting blood glucose after initiation of thiazide therapy in hypertensive patients. Am J Hypertens 21:438-442, 2008.
18. Cooper-DeHoff RM, Wen S, Beitelshees AL, et al. Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications. Hypertension 55:61-68, 2010.
19. Sowers JR, Raij L, Jialal I, et al. Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives. J Hypertens 28:1761-1769, 2010.
20. Zappe DH, Sowers JR, Hsueh WA, et al. Metabolic and antihypertensive effects of combined angiotensin receptor blocker and diuretic therapy in prediabetic hypertensive patients with the cardiometabolic syndrome. J Clin Hypertension 10:894-903, 2008.